Methods and materials for predicting responsiveness to...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S004000, C435S007100, C514S002600, C702S019000

Reexamination Certificate

active

07862995

ABSTRACT:
The present invention relates to a panel of targeted therapy markers that can be used in assessing a particular subject's sensitivity to various therapeutic agents and cancer treatments as a means of prognosticating whether a treatment or use of a particular therapeutic agent will result in a clinically positive outcome. Cellular receptors, ligands to those receptors and molecules involved in the programmed cell death pathway are examples of targeted therapy markers that might be used in the present invention.

REFERENCES:
Smith et al., Br. J. Cancer, 2004, vol. 91, pp. 1190-1194, Aug. 10, 2004.
Cobleigh et al., Journal of Clinical Oncology, vol. 17, pp. 2639-2648, 1999.
Perissi et al., Oncogene, vol. 19, pp. 280-288, 2000.
Bamberger et al., Hormone Research, vol. 54, pp. 32-37, 2000.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods and materials for predicting responsiveness to... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and materials for predicting responsiveness to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and materials for predicting responsiveness to... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2653159

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.